Influence of ACE I/D gene polymorphism in the progression of renal failure in autosomal dominant polycystic kidney disease: a meta-analysis

Nephrology Dialysis Transplantation

Volumn 21, Issue 11, 2006, Pages 3155-3163

  Pereira, Tiago Veiga ^a,c   Fernandes Nunes, Ane Cláudia ^b   Rudnicki, Martina ^c   Magistroni, Ricardo ^d   Albertazzi, Alberto ^d   Pereira, Alexandre Costa ^c   Krieger, José Eduardo ^c  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

ACE gene polymorphism; ADPKD; Autosomal dominant polycystic kidney disease; Meta analysis; Progression of renal failure

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ALLELE; ARTICLE; ASIAN; AUTOSOMAL DOMINANT DISORDER; CAUCASIAN; CLINICAL FEATURE; CONFIDENCE INTERVAL; DISEASE COURSE; ENZYME ACTIVITY; ENZYME POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; HYPERTENSION; KIDNEY FAILURE; KIDNEY POLYCYSTIC DISEASE; PRIORITY JOURNAL; PROGNOSIS; PUBLISHING; RANDOM SAMPLE; RISK ASSESSMENT; SYSTEMATIC REVIEW;

EID: 33749998687     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfl412     Document Type: Article

References (38)

1. Gabow PA. Autosomal dominant polycystic kidney disease. N Engl J Med 1993; 329: 332-342
2. Gabow PA, Ikle DW, Holmes JH. Polycystic kidney disease: Prospective analysis of nonazotemic patients and family members. Ann Intern Med 1984; 101: 238-247
3. Lockyer PJ. Europe needs a strategy to fight kidney disease. Nature 2004; 427: 584
4. Schrier RW, McFann KK, Johnson AM. Epidemiological study of kidney survival in autosomal dominant polycystic kidney disease. Kidney Int 2003; 63: 678-685
5. Devuyst O, Persu A, Vo-Cong MT. Autosomal dominant polycystic kidney disease: Modifier genes and endothelial dysfunction. Nephrol Dial Transplant 2003; 18: 2211-2215
6. Igarashi P, Somlo S. Genetics and pathogenesis of polycystic kidney disease. J Am Soc Nephrol 2002; 13: 2384-2398
7. Koptides M, Deltas CC. Autosomal dominant polycystic kidney disease: molecular genetics and molecular pathogenesis. Hum Genet 2000; 107: 115-126
8. Wu G, Tian X, Nishimura S et al. Trans-heterozygous Pkd1 and Pkd2 mutations modify expression of polycystic kidney disease. Hum Mol Genet 2002; 11: 1845-1854
9. Fain PR, McFann KK, Taylor MR et al. Modifier genes play a significant role in the phenotypic expression of PKD1. Kidney Int 2005; 67: 1256-1267
10. Crisan D, Carr J. Angiotensin I-converting enzyme: Genotype and disease associations. J Mol Diagn 2000; 2: 105-115
11. Pereira AC, Morandini Filho AA, Heimann AS et al. Serum angiotensin converting enzyme activity association with the I/D polymorphism in an ethnically admixtured population. Clin Chim Acta 2005; 360: 201-204
12. Agerholm-Larsen B, Nordestgaard BG, Tybjaerg-Hansen A. ACE gene polymorphism in cardiovascular disease: Metaanalyses of small and large studies in whites. Arterioscler Thromb Vasc Biol 2000; 20: 484-492
13. Chapman AB, Johnson A, Gabow PA, Schrier RW. The renin-angiotensin-aldosterone system and autosomal dominant polycystic kidney disease. N Engl J Med 1990; 323: 1091-1096
14. Thakkinstian A, McElduff P, D'Este C, Duffy D, Attia J. A method for meta-analysis of molecular association studies. Stat Med 2005; 24: 1291-1306
15. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-188
16. Egger M, Davey SG, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-634
17. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994; 50: 1088-1101
18. Uemasu J, Nakaoka A, Kawasaki H et al. Association between angiotensin converting enzyme gene polymorphism and clinical features in autosomal dominant polycystic kidney disease. Life Sci 1997; 60: 2139-2144
19. Hwang DY, Ahn C, Lee JG et al. ACE gene poymorphism of ADPKD in Korea. Abstracts of the 19th Scientific Meeting of the Korean Society of Nephrology 1999
20. Lee KB, Kim UK, Lee CC. Association of the ACE gene polymorphism with the progression of autosomal dominant polycystic kidney disease. J Korean Med Sci 2000; 15: 431-435
21. Konoshita T, Miyagi K, Onoe T et al. Effect of ACE gene polymorphism on age at renal death in polycystic kidney disease in Japan. Am J Kidney Dis 2001; 37: 113-118
22. Baboolal K, Ravine D, Daniels J et al. Association of the angiotensin I converting enzyme gene deletion polymorphism with early onset of ESRF in PKD1 adult polycystic kidney disease. Kidney Int 1997; 52: 607-613
23. Pérez-Oller L, Torra R, Badenas C, Mila M, Darnell A. Influence of the ACE gene polymorphism in the progression of renal failure in autosomal dominant polycystic kidney disease. Am J Kidney Dis 1999; 34: 273-278
24. Saggar-Malik AK, Afzal AR, Swissman JS et al. Lack of association of ACE/ angiotensinogen genotype with renal function in autosomal dominant polycystic kidney disease. Genet Test 2000; 4: 299-303
25. Magistroni R, Furci L, Leonelli M et al. I polimorfismi del gene dell'enzima di conversione dell'angiotensina (ACE) nel rene policistico autosomico dominante (ADPKD). Giornale Italiano di Nefrologia 2001; 18: 677-682
26. Schiavello T, Burke V, Bogdanova N et al. Angiotensin-converting enzyme activity and the ACE Alu polymorphism in autosomal dominant polycystic kidney disease. Nephrol Dial Transplant 2001; 16: 2323-2327
27. Merta M, Reiterova J, Stekrova J et al. Influence of the alpha-adducin and ACE gene polymorphism on the progression of autosomal-dominant polycystic kidney disease. Kidney Blood Press Res 2003; 26: 42-49
28. Persu A, El-Khattabi O, Messiaen T, Pirson Y, Chauveau D, Devuyst O. Influence of ACE (I/D) and G460W polymorphism of alpha-adducin in autosomal dominant polycystic kidney disease. Nephrol Dial Transplant 2003; 18: 2032-2038
29. Ecder T, McFann KK, Raynolds MV, Schrier RW. No effect of angiotensin-converting enzyme gene polymorphism on disease progression and left ventricular hypertrophy in autosomal dominant polycystic kidney disease. Am J Nephrol 2003; 23: 466-470
30. Nunes ACF, Milani V, Porsch D et al. Genótipos ECA I/D, PAI-1 4G/5G e MTHFR C677T em Pacientes Submetidos à Hemodiálise no Sul do Brasil. Anais do XXII Congresso Brasileiro de Nefrologia 2004
31. Pereira AC, Mota GA, Bensenor I, Lotufo PA, Krieger JE. Effect of race, genetic population structure, and genetic models in two-locus association studies: Clustering of functional renin-angiotensin system gene variants in hypertension association studies. Braz J Med Biol Res 2001; 34: 1421-1428
32. Thompson SG, Higgins JP. How should meta-regression analyses be undertaken and interpreted? Stat Med 2002; 21: 1559-1573
33. Paterson AD, Magistroni R, He N et al. Progressive loss of renal function is an age-dependent heritable trait in type 1 autosomal dominant polycystic kidney disease. J Am Soc Nephrol 2005; 16: 755-762
34. Neugarten J, Acharya A, Silbiger SR. Effect of gender on the progression of nondiabetic renal disease: A meta-analysis. J Am Soc Nephrol 2000; 11: 319-329
35. Klahr S, Breyer JA, Beck GJ et al. Dietary protein restriction, blood pressure control, and the progression of polycystic kidney disease. Modification of Diet in Renal Disease Study Group. J Am Soc Nephrol 1995; 5: 2037-2047
36. Newman DL, Abney M, McPeek MS, Ober C, Cox NJ. The importance of genealogy in determining genetic associations with complex traits. Am J Hum Genet 2001; 69: 1146-1148
37. Slager SL, Schaid DJ. Evaluation of candidate genes in case-control studies: A statistical method to account for related subjects. Am J Hum Genet 2001; 68: 1457-1462
38. Pereira AC, Pereira AB, Mota GF et al. NPHS2 R229Q functional variant is associated with microalbuminuria in the general population. Kidney Int 2004; 65: 1026-1030